ARCHIVES

Phase III Study: Lymphoseek Superior to Vital Blue Dye

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975

Institute of Medicine Elects 80 New Members

October 24, 2014

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

NCI considers allowing some centers to opt out of site visits.

March 19, 2004

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007